(AKTX) Akari Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Akari Therapeutics | (AKTX) share price targets
Complete technical analysis of Akari Therapeutics (AKTX) by charts plus indicators, forecast predictions and share price targets for Akari Therapeutics (AKTX)
Akari Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Akari Therapeutics is 1713021
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Wed Dec 2025 | 0.34 | 0.35 | 0.35 | 0.29 | 0.456 times |
| 02 Tue Dec 2025 | 0.35 | 0.41 | 0.60 | 0.32 | 9.346 times |
| 01 Mon Dec 2025 | 0.40 | 0.48 | 0.48 | 0.40 | 0.138 times |
| 28 Fri Nov 2025 | 0.49 | 0.46 | 0.50 | 0.45 | 0.035 times |
| 26 Wed Nov 2025 | 0.45 | 0.48 | 0.49 | 0.44 | 0.067 times |
| 25 Tue Nov 2025 | 0.45 | 0.46 | 0.46 | 0.43 | 0.045 times |
| 24 Mon Nov 2025 | 0.44 | 0.45 | 0.47 | 0.42 | 0.096 times |
| 21 Fri Nov 2025 | 0.45 | 0.47 | 0.47 | 0.44 | 0.05 times |
| 20 Thu Nov 2025 | 0.46 | 0.49 | 0.55 | 0.45 | 0.05 times |
| 19 Wed Nov 2025 | 0.50 | 0.54 | 0.54 | 0.49 | 0.055 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 0.4, but if it comes above 0.4, then a intra day buy could be more profitable.
If you take a sell trade below 0.4, then use 0.4 as stoploss and 0.3 as target. However if you take a buy trade in stock , then use 0.4 as stoploss and 0.5 as target.
Share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Target | 0.29 |
| Upside Target | 0.42 |
| Upside Target | 0.44 |
| Upside Target | 0.50 |
| Upside Target | 0.55 |
| Upside Target | 0.57 |
| Upside Target | 0.60 |
| Upside Target | 0.65 |
| Upside Target | 0.70 |
| Upside Target | 0.75 |
| Upside Target | 0.84 |
| Upside Target | 1.11 |
| Upside Target | 1.13 |
| Upside Target | 1.24 |
Intraday share price targets for Akari Therapeutics (AKTX)
| Target Type | Value |
| Downside Intraday Target | 0.22 |
| Downside Intraday Target | 0.1 |
| Upside Intraday Target | 0.53 |
| Upside Intraday Target | 0.72 |
| Upside Intraday Target | 0.41 |
Weekly technical analysis of Akari Therapeutics (AKTX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Wed Dec 2025 | 0.34 | 0.48 | 0.60 | 0.29 | 40.952 times |
| 28 Fri Nov 2025 | 0.49 | 0.45 | 0.50 | 0.42 | 0.583 times |
| 21 Fri Nov 2025 | 0.45 | 0.51 | 0.55 | 0.44 | 0.653 times |
| 14 Fri Nov 2025 | 0.53 | 0.64 | 0.65 | 0.50 | 0.75 times |
| 07 Fri Nov 2025 | 0.64 | 0.78 | 0.84 | 0.60 | 10.366 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Akari Therapeutics (AKTX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Wed Dec 2025 | 0.34 | 0.48 | 0.60 | 0.29 | 4.634 times |
| 28 Fri Nov 2025 | 0.49 | 0.78 | 0.84 | 0.42 | 1.311 times |
| 31 Fri Oct 2025 | 0.75 | 0.99 | 1.11 | 0.70 | 0.281 times |
| 30 Tue Sep 2025 | 1.01 | 0.77 | 1.24 | 0.57 | 10.842 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Akari Therapeutics (AKTX)
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Akari Therapeutics in short term and the sell signal is strong.
Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.35 and Akari Therapeutics (AKTX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akari Therapeutics ( (AKTX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akari Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Akari Therapeutics in short term and the sell signal is strong.
Akari Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akari Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akari Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.35 and Akari Therapeutics (AKTX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akari Therapeutics (AKTX) stock. Volume based technical analysis of Akari Therapeutics (AKTX) stock is negative.
Akari Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

